Also - students can no more pay for a roast chook with $230,000 worth of CYP shares without selling them either. Academic credit is not nothing - its what the Nature Medicine article had.
And the same argument you are making about needing to have all aspects of a technological solution bundled up free and clear applies to having 3D manufacturing solutions not just 2D manufacturing solutions. Kilian said - with cells - the process is the product. Well 3D manufacturing is a different process to 2D manufacturing. Cynata doesn't have currently and doesn't appear to be developing currently a 3D manufactured product. Any partner needing to develop that could only see Cynata as having a partial manufacturing solution and pay accordingly for only part of a manufacturing solution.
- Forums
- ASX - By Stock
- CYP
- Ann: Cynata to Acquire IP from Tekcyte
CYP
cynata therapeutics limited
Add to My Watchlist
3.03%
!
16.0¢

Ann: Cynata to Acquire IP from Tekcyte, page-33
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
-0.005(3.03%) |
Mkt cap ! $36.15M |
Open | High | Low | Value | Volume |
16.5¢ | 16.5¢ | 16.0¢ | $73.23K | 457.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 31250 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 27550 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 31250 | 0.160 |
4 | 148709 | 0.155 |
5 | 136673 | 0.150 |
1 | 35000 | 0.140 |
2 | 35937 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 27550 | 2 |
0.170 | 70000 | 2 |
0.175 | 77450 | 2 |
0.180 | 146968 | 5 |
0.185 | 35990 | 1 |
Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |